Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings

Clinical trial NCT02440854 · COMPLETED

Trial details

NCT number: NCT02440854
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2016-02-16
Primary completion: 2021-02-17
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.